Article metrics

Download PDFPDF

Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic

 

Online download statistics by month:

Online download statistics by month: May 2021 to July 2022

AbstractFullPdf
May 202110410433
Jun 20211049827
Jul 202141415
Aug 202151516
Sep 2021414116
Oct 2021384024
Nov 2021444431
Dec 202115015350
Jan 202217117354
Feb 2022656226
Mar 2022595540
Apr 2022484920
May 2022544940
Jun 2022646020
Jul 2022656116
Total10991081408